CCI Clinical Trials Team Serves Cancer Patients Near, Far

The team at Clearview Cancer Institute has been involved in cancer research for more than three decades.  We have a department dedicated to research and clinical trials.  Our commitment remains with new targeted therapies, better detection methods, genomic testing and personalized medicine. 

Pictured: Lisa Chapuran, Mary Hughes, Mariam Parizad, Leslie Smoot

Did you know:

  • The CCI research team has participated in the FDA approval of the following medications: Herceptin, Avastin, Rituxan and more.
  • The CCI research team has a combined 30 years experience in research including 4 RNs that serve as study coordinators, a regulatory/investigational product coordinator, and a lab and registry coordinator.
  • Clinical trials have improved childhood cancer survival from less than 10% to 80% survival.
  • Clinical trials can allow access to therapies that are up and coming and not available otherwise.
  • Developing new medicine takes at least 10 years on average to receive FDA approval.
  • Clinical trials look at new ways to prevent, detect, or treat disease.
  • Groundbreaking scientific advances in the present and the past were possible only because of participation of volunteers, both healthy and those diagnosed with an illness, in clinical research.

A special thanks to these physicians who serve as primary investigators:

Dr. Paul Dang

Dr. Jorge Diaz

Dr. Kanth Katragadda

Dr. Brian Mathews

Dr. Daniel Schreeder

Dr. Marshall Schreeder

Patient Portal Notice

Clearview Cancer Institute has started using a new patient portal, called Noona, in order to better connect patients with their care team.

If you have an email address on file, be on the lookout for an invitation email to sign up. Your care team can also help you register during your next visit. CareSpace will be available for a limited time.

Continue to CareSpace